Evaluation of an in Vitro Assay Aimed at Measuring Protective Antibodies against Sporozoites
Abstract
The feasibility of successfully developing a vaccine against sporozoite challenge has rested largely on successes in protecting mice and some humans with irradiated sporozoites. Several studies have indicated that antibodies (5), CD8+ T cells, and cytokines released by immuno-competent cells can interfere with the pre-erythrocytic phase of parasite development. However, information from malaria animal models have demonstrated that antibodies alone, either monoclonal (MAb) or polyclonal, can be fully or partially effective in preventing infection in sporozoite challenged animals.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 1990
- Accession Number
- ADA235904
Entities
People
- B. Galey
- C. Paul
- L. Yuan
- M. Leef
- M. Sedegah
- N. Berbiguier
- P. Druilhe
- R. Beaudoin
- S. Mellouk
- Samantha N. Hoffman
- Y. Charoenvit
Organizations
- Naval Medical Research Center